Table 2.
Prevalence of depression and anxiety.
Reference | Symptoms of Depression | Symptoms of Anxiety | Comparator |
---|---|---|---|
Depression and Anxiety | |||
[24] | ↑ Pregnancy—25.3%; postpartum 23.6% | ↑ 39.4% mild; 13.6% moderate-to-severe anxiety | Estimates in Belgium prior to the pandemic |
[25] | ↑ | ↑ | Pre-pandemic cohort |
[26] | ↑ 37% | ↑ 57% | Similar pre-pandemic pregnancy cohorts |
[28] | ↑ 50.6% | ↔ 8.3% | Literature data |
[29] | ↓ 5.3% | ↓ 6.8% | Non-pregnant women during pandemic |
[30] | 19.2% | 31.2% | None |
[31] | ↑ 34.2% (pregnant women) ↑ 26.3% (postpartum women) |
↑ 64% (pregnant women) ↑ 57.7% (postpartum women) |
Literature data |
[32] | 35.4% | None | |
[33] | ↑ | ↑ | Test–retest study |
[34] | 56.3% | 64.5% | None |
[35] | 12% | 60% | None |
[36] | 9.9% | 11.1% | None |
[37] | ↑ 39.2% | ↑ 34.4% | Literature data |
Depression | |||
[38] | ↑ 29.6% | Pre-alert group | |
[39] | ↑ 14.4% | Pre-alert group | |
[40] | ↔ 25.0% | Pre-pandemic hospitalized high-risk pregnancy group | |
[41] | ↑ 28.6% | Pre-pandemic control group | |
[42] | 17% | None | |
[43] | 14.7% | None | |
[44] |
↓ score ≥ 9 in EPDS—15.1% score ≥ 12 8.2% |
Pre-restriction group | |
[45] | 24% | None | |
Anxiety | |||
[46] | 17.2% | None | |
[47] | ↑ 14.3% | General population prior to COVID-19 | |
[49] | ↑ 77.0% | Literature data | |
[50] | 68% | None | |
[51] | ↑ 62.6% | Literature data | |
[52] | Mild—35.6%; moderate—21.6%; severe anxiety symptoms—21.7% | None |
Meaning of the symbols: ↑—higher than the comparator, ↓—lower than the comparator, ↔ similar to the comparator.